Creative Biogene offers a rapid, flexible profiling and screening service for potential drug inhibitors of histone acetyltransferases (HATs), including small molecules, peptides, and antibodies. Creative Biogene provides two assay platforms, radioisotope based assays and fluorogenic based functional assays. These two highly sensitive and highly reproducible assays can quickly identify potential therapeutics, predict potency, and narrow down a large pool of candidates to a much smaller one.